Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Discovery Life Sciences™ has acquired Targos Molecular Pathology GmbH, Germany, one of the largest molecular pathology laboratories in Europe.
read more
Thursday, December 02, 2021
Discovery Life Sciences™ has acquired In Vitro ADMET Laboratories to add the world's largest hepatocyte inventory and a world-renowned scientific leader to its growing company.
read more
Discovery Life Sciences™ has acquired AllCells®, a provider of clinical-grade (GMP-compliant) and Research Use Only (RUO) primary cell products. With more than 30 years of collective cell and gene therapy (CGT) experience, AllCells and Discovery will...
read more
Discovery Life Sciences™ has acquired Seattle-based ReachBio Research Labs (ReachBio®), a company specializing in cell-based assays, predictive hematotoxicity, and drug screening services.
read more
Discovery Life Sciences announced the launch of state-of-the-art flow cytometry clinical trial services.
read more
Discovery Life Sciences has moved to its new global headquarters at the HudsonAlpha Institute of Biotechnology campus in Huntsville, Alabama. Alongside this relocation, the company's AllCells cell and gene therapy division has set up its new ...
read more
Tuesday, November 07, 2023
Discovery Life Sciences announced the appointment of Greg Herrema as its new chief executive officer. A leader with more than 20 years of experience across the life sciences and industrial sectors, Mr. Herrema will spearhead the next phase of ...
read more
Tuesday, November 03, 2020
Discovery Life Sciences announces the expansion of their HudsonAlpha Discovery PacBio Center of Excellence with the purchase of additional Sequel® II Systems.
read more
Thursday, October 05, 2023
Discovery Life Sciences announced it has expanded its high-throughput proteomics services with the addition of Olink Explore HT. A next-generation proteomics solution, the new Olink Explore HT platform achieves greater precision and speed—enhancing ...
read more
Thursday, February 17, 2022
Discovery Life Sciences™ announced the expansion of its GMP-compliant, clinical-grade product portfolio with the launch of Discovery Cryo Leukopaks™ (GMP). The company's extended capabilities around GMP-compliant cellular starting materials will ease...
read more
Discovery Life Sciences™ has acquired the Gentest® business unit, part of Corning Incorporated's Life Sciences business. The acquisition of Gentest complements Discovery's recent acquisition of In Vitro ADMET Laboratories, LLC (IVAL) in December of ...
read more
Wednesday, August 04, 2021
DisperSol Technologies, a clinical-stage pharmaceutical company developing new treatments for oncology and rare diseases, and Catalent, a global provider of advanced delivery technologies...
read more
Monday, December 11, 2017
Distributed Bio announced an agreement with Boehringer Ingelheim to license the Distributed Bio SuperHuman Platform.
read more
Thursday, December 02, 2021
Combatting the pandemic has highlighted the importance of the partnership between biopharma organizations and the contract manufacturing organizations (CMOs) that must flexibly handle outsourced production, which can come suddenly and often must ...
read more
Wednesday, March 23, 2016
Diversigen a provider of comprehensive microbiome analysis services, has announced a strategic partnership with BioCore Co. Ltd., a bioanalytical contract research organization, based in Seoul, South Korea.
read more